Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator Based on Discrete-Event Simulations.
Çaglayan Ç, Thornhill J, Stewart MA, Lambrou AS, Richardson D, Rainwater-Lovett K, Freeman JD, Pfundt T, Redd JT. Çaglayan Ç, et al. Among authors: thornhill j. Front Public Health. 2022 Jan 28;9:770039. doi: 10.3389/fpubh.2021.770039. eCollection 2021. Front Public Health. 2022. PMID: 35155339 Free PMC article.
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency Use.
Lambrou AS, Redd JT, Stewart MA, Rainwater-Lovett K, Thornhill JK, Hayes L, Smith G, Thorp GM, Tomaszewski C, Edward A, Elías Calles N, Amox M, Merta S, Pfundt T, Callahan V, Tewell A, Scharf-Bell H, Imbriale S, Freeman JD, Anderson M, Kadlec RP. Lambrou AS, et al. Disaster Med Public Health Prep. 2022 Jan 14;17:e112. doi: 10.1017/dmp.2022.15. Disaster Med Public Health Prep. 2022. PMID: 35027098 Free PMC article.
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States.
Rainwater-Lovett K, Redd JT, Stewart MA, Calles NE, Cluff T, Fang M, Panaggio MJ, Lambrou AS, Thornhill JK, Bradburne C, Imbriale S, Freeman JD, Anderson M, Kadlec RP. Rainwater-Lovett K, et al. Among authors: thornhill jk. Open Forum Infect Dis. 2021 Jul 24;8(8):ofab398. doi: 10.1093/ofid/ofab398. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34409125 Free PMC article.
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study.
Alagaratnam J, Thornhill JP, Fan Z, Vera JH, Underwood J, Hall R, Searle G, Owen D, Edison P, Fidler S, Winston A. Alagaratnam J, et al. Among authors: thornhill jp. J Neurovirol. 2024 Apr 4. doi: 10.1007/s13365-024-01200-3. Online ahead of print. J Neurovirol. 2024. PMID: 38575831
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.
Zacharopoulou P, Lee M, Oliveira T, Thornhill J, Robinson N, Brown H, Kinloch S, Goulder P, Fox J, Fidler S, Ansari MA, Frater J. Zacharopoulou P, et al. Among authors: thornhill j. Front Immunol. 2024 Mar 18;15:1352123. doi: 10.3389/fimmu.2024.1352123. eCollection 2024. Front Immunol. 2024. PMID: 38562938 Free PMC article.
298 results